Aurexis Uses, Dosage, Side Effects and more
Aurexis is under investigation in clinical trial NCT00198289 (Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs).
| Attribute | Details |
|---|---|
| Trade Name | Aurexis |
| Generic | Tefibazumab |
| Tefibazumab Other Names | Tefibazumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
